Maverick Capital’s Smith & Wesson SWBI Stock Holding History

Maverick Capital’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,770	Closed	-$67K	–	364
2021 Q4	$67K	Buy	+3,770	New	+$77.8K	﹤0.01%	281
2020 Q4	–	Sell	-24,728	Closed	-$384K	–	776
2020 Q3	$384K	Buy	+24,728	New	+$437K	0.01%	441

Other funds holding SWBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Maverick Capital's SWBI Position: Q1 2022 in Review

Maverick Capital sold out of Smith & Wesson (SWBI) in Q1 2022, closing a stake of 3,770 shares — an estimated $67K sold.

Maverick Capital first reported a position in SWBI in Q3 2020 and held it in 2 quarters. The position peaked at $384K in Q3 2020. 223 funds tracked by Wall St. Rank hold SWBI as of Q1 2022.

Maverick Capital reported no remaining Smith & Wesson position as of Q1 2022 after selling out during the quarter.
Maverick Capital sold 3,770 Smith & Wesson shares in Q1 2022, an estimated $67K.
Maverick Capital first reported a position in Smith & Wesson in Q3 2020 and held it in 2 quarters.
Maverick Capital's Smith & Wesson position peaked at $384K in Q3 2020.
223 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2022.

Based on Maverick Capital's 13F filing for Q1 2022, filed 16 May 2022.